- Home
- NCLH vs PRME Comparison
NCLH vs PRME Comparison
Compare NCLH & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCLH | PRME |
|---|---|---|
| Founded | 1966 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 601.1M |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NCLH | PRME |
|---|---|---|
| Price | $20.86 | $4.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 6 |
| Target Price | ★ $28.89 | $9.31 |
| AVG Volume (30 Days) | ★ 15.3M | 3.7M |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $9,692,558,000.00 | $5,977,000.00 |
| Revenue This Year | $6.85 | $111.80 |
| Revenue Next Year | $10.76 | N/A |
| P/E Ratio | $14.93 | ★ N/A |
| Revenue Growth | 3.59 | ★ 647.13 |
| 52 Week Low | $14.21 | $1.11 |
| 52 Week High | $29.29 | $6.94 |
Technical Indicators
Market Signals| Indicator | NCLH | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 52.01 |
| Support Level | $18.51 | $3.95 |
| Resistance Level | $19.23 | $4.42 |
| Average True Range (ATR) | 0.63 | 0.30 |
| MACD | 0.42 | 0.12 |
| Stochastic Oscillator | 86.83 | 76.72 |
Price Performance
Historical ComparisonAbout NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.